|
KDSR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.099600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.91799999996289E-06 |
| Normal-vs-Stage2 |
1.361750E-01 |
| Normal-vs-Stage3 |
8.115000E-01 |
| Normal-vs-Stage4 |
9.015400E-01 |
| Stage1-vs-Stage2 |
3.987200E-01 |
| Stage1-vs-Stage3 |
2.952400E-04 |
| Stage1-vs-Stage4 |
4.620300E-04 |
| Stage2-vs-Stage3 |
2.009000E-01 |
| Stage2-vs-Stage4 |
1.340790E-01 |
| Stage3-vs-Stage4 |
7.626000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.796590E-03 |
| Normal-vs-AfricanAmerican |
9.859600E-01 |
| Normal-vs-Asian |
5.492400E-01 |
| Caucasian-vs-AfricanAmerican |
1.354470E-02 |
| Caucasian-vs-Asian |
9.087200E-01 |
| AfricanAmerican-vs-Asian |
5.501600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.899800E-02 |
| Normal-vs-Female |
6.824400E-04 |
| Male-vs-Female |
4.996100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.551600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.834600E-04 |
| Normal-vs-Age(61-80Yrs) |
5.180000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.307000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.595700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.272000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.558200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.338400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.104200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.515600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.436100E-03 |
| Normal-vs-Grade 2 |
2.87650000041495E-07 |
| Normal-vs-Grade 3 |
1.838200E-01 |
| Normal-vs-Grade 4 |
1.464120E-02 |
| Grade 1-vs-Grade 2 |
9.127400E-01 |
| Grade 1-vs-Grade 3 |
9.715900E-02 |
| Grade 1-vs-Grade 4 |
7.230600E-04 |
| Grade 2-vs-Grade 3 |
8.39880000000903E-05 |
| Grade 2-vs-Grade 4 |
1.95639948685766E-10 |
| Grade 3-vs-Grade 4 |
7.618700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.09069975273712E-10 |
| Normal-vs-ccB subtype |
7.064600E-01 |
| ccA subtype-vs-ccB subtype |
1.57660551280969E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.268000E-02 |
| Normal-vs-N1 |
6.870600E-01 |
| N0-vs-N1 |
7.379400E-01 |
|
|
